ICORG 10-14: NEOadjuvant trial in Adenocarcinoma of the oEsophagus and oesophagoGastric junction International Study (Neo-AEGIS)

Abstract Background Neoadjuvant therapy is increasingly the standard of care in the management of locally advanced adenocarcinoma of the oesophagus and junction (AEG). In randomised controlled trials (RCTs), the MAGIC regimen of pre- and postoperative chemotherapy, and the CROSS regimen of preoperat...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	JV Reynolds, SR Preston, B O’Neill, L Baeksgaard, SM Griffin, C Mariette, S Cuffe, M Cunningham, T Crosby, I Parker, K Hofland, G Hanna, LB Svendsen, CL Donohoe, C Muldoon, D O’Toole, C Johnson, N Ravi, G Jones, AK Corkhill, M Illsley, J Mellor, K Lee, M Dib, V Marchesin, M Cunnane, K Scott, P Lawner, S Warren, S O’Reilly, G O’Dowd, G Leonard, B Hennessy, R Mc Dermott
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	BMC 2017-06-01
سلاسل:	BMC Cancer
الموضوعات:	Oesophageal Oesophagogastric junction Adenocarcinoma Neoadjuvant chemoradiation therapy Neoadjuvant chemotherapy
الوصول للمادة أونلاين:	http://link.springer.com/article/10.1186/s12885-017-3386-2
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!